Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 123

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 123
---
0.2 million. 

Nine Months Ended September 30, 2025 vs. 2024 

SG&A was $129.6 million (14 percent of Net sales) and $119.5 million (13 percent of Net sales) for the nine months ended September 30, 2025 and 2024, respectively. Overall, SG&A increased by $10.1 million (eight percent), driven by increased variable incentive compensation of $10.2 million, partially offset by decreased spending on commercial activities of $0.1 million.

Research and technical expenses

Three Months Ended September 30, 2025 vs 2024

Research and technical expenses as a percentage of Net sales was 2.1 percent and 1.9 percent for the three months ended September 30, 2025 and 2024, respectively. Overall, Research and technical expenses increased by $0.8 million, compared to the prior year quarter, primarily driven by an increase within our Performance Materials reportable segment. 

Nine Months Ended September 30, 2025 vs. 2024 

Research and technical expenses as a percentage of Net sales was 2.3 percent and 1.9 percent for the nine months ended September 30, 2025 and 2024, respectively. Research and technical expenses as a percentage of Net sales increased due to lower sales. Overall, Research and technical expenses increased by $3.0 million, compared to the prior year, primarily driven by an increase within our Performance Materials reportable segment. 

38

Restructuring and other (income) charges, net

Three and Nine Months Ended September 30, 2025 vs. 2024 

Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Work force reductions and other $0.3 $— $8.0 $— Performance Chemicals repositioning0.7 2.0 2.1 3.4 Restructuring charges$1.0 $2.0 $10.1 $3.4 North Charleston plant transition— 1.3 — 4.9 Other (income) charges, net$— $1.3 $— $4.9 Restructuring and other (income) charges, net (1)$1.0 $3.3 $10.1 $